Espín Balbino Jaime, Brosa Riestra Max, Oliva Moreno Juan, Trapero-Bertran Marta
Rev Esp Salud Publica. 2015 May-Jun;89(3):237-47. doi: 10.4321/S1135-57272015000300002.
The development of the economic evaluation of health care interventions has become a support tool in making decisions on pricing and reimbursement of new health interventions. The increasingly extensive application of these techniques has led to the identification of particular situations in which, for various reasons, it may be reasonable to take into account special considerations when applying the general principles of economic evaluation. In this article, which closes a series of three, we will discuss, using the Metaplan technique, about the economic evaluation of health interventions in special situations such as rare diseases and end of life treatments, as well as consideration of externalities in assessments, finally pointing out some research areas to solve the main problems identified in these fields.
医疗保健干预措施的经济评估发展已成为在新医疗干预措施定价和报销决策中的一种支持工具。这些技术的日益广泛应用已导致识别出特定情况，在这些情况下，出于各种原因，在应用经济评估的一般原则时考虑特殊因素可能是合理的。在这篇作为三篇系列文章结尾的文章中，我们将使用Metaplan技术讨论特殊情况下（如罕见疾病和临终治疗）医疗干预措施的经济评估，以及评估中对外部性的考虑，最后指出一些研究领域以解决这些领域中确定的主要问题。
